Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Trial
Effects of Intensive Blood Pressure and Combination Lipid Therapies in Type 2 Diabetes
Announcements — March 14, 2008
NEJM Editorials and Perspective:
Effects of Intensive Glucose Lowering in Type 2 Diabetes
Announcements — June
6, 2008
NEJM Editorials and Perspective:
- Intensive
Glycemic Control in the ACCORD and ADVANCE Trials,
Robert G. Dluhy, M.D., and Graham T. McMahon, M.D., M.M.Sc.
- Glycemic
Targets and Cardiovascular Disease, William T. Cefalu,
M.D.
- Redefining
Quality - Implications of Recent Clinical Trials,
Harlan M. Krumholz, M.D., and Thomas H. Lee, M.D.
ACCORD Blood Sugar Strategy Announcement — February
6, 2008
Last updated: March 22, 2011
|